Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFJP | ISIN: US65345B2016 | Ticker-Symbol:
NASDAQ
06.06.25 | 21:15
1,280 US-Dollar
+6,67 % +0,080
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXALIN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
NEXALIN TECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur NEXALIN TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln
30.05.RedChip Companies, Inc.: Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV78ORLANDO, FL / ACCESS Newswire / May 30, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and FatPipe, Inc. (Nasdaq:FATN) on the RedChip Small Stocks, Big Money...
► Artikel lesen
28.05.Nexalin Technology, Inc.: Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 31
28.05.Nexalin Technology: EPS verfehlt Schätzungen um 0,02 $ - Umsatz besser als erwartet1
13.05.Nexalin Technology, Inc. - 10-Q, Quarterly Report2
06.05.Nexalin Technology, Inc.: Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering1
05.05.Nexalin Prices 3.85 Mln Public Offering At $1.30/shr; Stock Plunges In Pre-market1
05.05.Nexalin Technology slides after pricing $5M stock offering3
05.05.Nexalin Technology legt öffentliches Angebot bei 1,30 US-Dollar pro Aktie fest1
05.05.Nexalin Technology sets public offering at $1.30 per share1
05.05.Nexalin Technology, Inc.: Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock1
05.05.Nexalin Technology, Inc. - 8-K, Current Report1
01.05.Nexalin Technology, Inc.: Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback122HOUSTON, TX, May 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), today announced that it plans to submit a Q-Submission ("Q-Sub") to the U.S....
► Artikel lesen
24.04.Nexalin Technology, Inc.: Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia127HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain...
► Artikel lesen
23.04.Nexalin Technology files $50M common stock offering1
23.04.Nexalin Technology, Inc.: Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO Clinical Research and Patient Management149HOUSTON, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain...
► Artikel lesen
21.04.Nexalin Technology, Inc.: Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices3
17.04.Nexalin Technology, Inc. - 8-K, Current Report1
14.04.Nexalin Technology, Inc.: Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS) Technology in Treating Substance Use Disorders2
02.04.Nexalin begins clinical trial for brain stimulation therapy2
02.04.Nexalin beginnt klinische Studie für Gehirnstimulationstherapie2
Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1